ArticleCureus2025
Hepatic Encephalopathy Induced by Small Bowel Obstruction in a Patient With Primary Biliary Cholangitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Continuation of sedative infusions during palliative extubation for refractory status epilepticus in hepatic encephalopathy: A case report.SAGE open medical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic encephalopathy (HE) represents a spectrum of neuropsychiatric abnormalities resulting from hepatic dysfunction. This case report discusses the case of a 66-year-old woman with a known diagnosis of primary biliary cholangitis (PBC) who presented with a 10-day history of constipation, vomiting, and progressive cognitive decline. Cross-sectional imaging of the abdomen revealed a large ventral hernia in the anterior midline containing multiple loops of small bowel, consistent with adhesional small bowel obstruction. Laboratory investigations demonstrated elevated ammonia levels and deranged liver function tests (LFTs), consistent with the clinical picture of HE. The patient was managed conservatively with bowel decompression, and HE was successfully treated with rifaximin and, following the resolution of the obstruction, with lactulose. The patient made a good neurological recovery with normalization of biochemical markers and was discharged from the intensive care unit (ICU) in a stable condition. This case underscores the importance of recognizing and promptly addressing reversible precipitants of HE and illustrates the challenges of managing HE in the context of gastrointestinal obstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.